Annette Kleiser
Amministratore Delegato presso Dalan Animal Health, Inc.
Profilo
Annette Kleiser is the Chief Executive Officer & Director at Dalan Animal Health, Inc. She previously worked as a Senior Manager-Licensing at Amgen, Inc. and as Vice President-Business Development at Allon Therapeutics, Inc. from 2007 to 2008.
Dr. Kleiser holds a graduate degree from Universität Konstanz and a doctorate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Annette Kleiser
| Società | Posizione | Inizio |
|---|---|---|
Dalan Animal Health, Inc.
 Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Amministratore Delegato | 01/12/2018 |
Precedenti posizioni note di Annette Kleiser
| Società | Posizione | Fine |
|---|---|---|
| ALLON THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2008 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Annette Kleiser
| Universität Konstanz | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dalan Animal Health, Inc.
Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Health Technology |
- Borsa valori
- Insiders
- Annette Kleiser
